Dr. Reddy’s Laboratories debuts generic version of KOMBIGLYZE XR in US
In a significant development for diabetes treatment in the U.S., Dr. Reddy’s Laboratories has unveiled its Saxagliptin and Metformin Hydrochloride Extended-Release Tablets. This launch introduces a therapeutic equivalent to the widely prescribed KOMBIGLYZE XR (saxagliptin and metformin hydrochloride extended release) tablets, with the endorsement of the US Food and Drug Administration (FDA). The Indian pharmaceutical […]